These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1225110)

  • 1. [Pharmacological study of some capillaro-active substances].
    Tarayre JP; Lauressergues H
    Ann Pharm Fr; 1975 Oct; 33(10):467-71. PubMed ID: 1225110
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect on the capillary permeability of an escin-cyclonamine association].
    De Pascale V; Bamonte F; Lavezzari E; Craveri F; Frigo GM; Crema A
    Boll Chim Farm; 1974 Nov; 113(11):600-14. PubMed ID: 4464898
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy.
    Berthet P; Farine JC; Barras JP
    Int J Clin Pract; 1999 Dec; 53(8):631-6. PubMed ID: 10692760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect on the capillary resistance, time of hemorrhage and coagulation of an escin-cyclonamine association].
    De Pascale V; Lavezzari E; Bamonte F; Craveri F; Lecchini S; Crema A
    Boll Chim Farm; 1974 Dec; 113(12):660-73. PubMed ID: 4464907
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibition of capillary permeability by a combination of pyridinolcarbamate and adenosine].
    Igual A; Vericat Cadesas F; Beaus R
    Arch Farmacol Toxicol; 1978 Apr; 4(1):88-9. PubMed ID: 697407
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
    Rota R; Chiavaroli C; Garay RP; Hannaert P
    Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of angioprotectors on the glomerular filtration rate and vascular permeability in diabetic angiopathies].
    Tirkina TN; Mirkhodzhaev AKh; Alekseev IuP; Ionushas BS; Kasymova SD
    Probl Endokrinol (Mosk); 1979; 25(4):11-6. PubMed ID: 471968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium dobesilate: pharmacology and future approaches.
    Tejerina T; Ruiz E
    Gen Pharmacol; 1998 Sep; 31(3):357-60. PubMed ID: 9703201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is new about the treatment of diabetic retinopathy by calcium dobesilae (Doxium).
    Cuendet JF; Sevin R
    Bull Ophthalmol Soc Egypt; 1976; 69(73):469-74. PubMed ID: 1031108
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacology of the drugs prescribed for chronic venous diseases].
    Talibov OB
    Khirurgiia (Mosk); 2019; (2):106-109. PubMed ID: 30855600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diosmin in the treatment of venous disease: pharmacokinetics and pharmacodynamics (in Russian only)].
    Talibov OB
    Khirurgiia (Mosk); 2019; (3):135-140. PubMed ID: 30938369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pyridinolcarbamate (PDC) on surface microvessels in man: preliminary findings.
    Rouen LR; Terry EN; Clauss RH; Redisch W
    Bibl Anat; 1975; 13():358-9. PubMed ID: 1231780
    [No Abstract]   [Full Text] [Related]  

  • 13. [5 years experimentation with calcium dobesilate in the treatment of retinopathies].
    Sévin R; Cuendet J-F
    Ophthalmologica; 1975; 170(2-3):232-8. PubMed ID: 1134739
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical effectiveness of venotonic drugs: a meta-analysis.
    Boada J; Nazco J
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():15-8. PubMed ID: 8899687
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of pyridinolcarbamate (parmidine) on some bradykinin effects].
    Shvarts GIa; Mashkovskiĭ MD
    Farmakol Toksikol; 1976; 39(2):176-9. PubMed ID: 1278349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a flavonoid preparation (S 5682) on experimental capillary permeability increase in rat paw and rabbit skin.
    Godfraind T
    Int Angiol; 1988; 7(2 Suppl):17-9. PubMed ID: 3183452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of drugs--especially flavonoids and aescin--on the lymph flow and the permeability of the intact plasma-lymph barrier of rats for fluid and defined macromolecules].
    Vogel G; Ströcker H
    Arzneimittelforschung; 1966 Dec; 16(12):1630-4. PubMed ID: 6014798
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies to the effect of drugs on the plasmalymph-barrier of rats after the estabolshment of a condition of increased capillary permeability].
    Vogel G; Wendt B; Ströcker H
    Arzneimittelforschung; 1967 Apr; 17(4):454-8. PubMed ID: 4386770
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of flavonoids on capillary permeability, carrageenin edema and histamine and PGE2 spasms.
    Metzner J; Bekemeier H; Weber FG
    Agents Actions Suppl; 1982; 10():129-34. PubMed ID: 6956213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect on capillary permeability of some natural and half-synthetic flavonoids in mice].
    Gábor M; Engi E
    Acta Pharm Hung; 1987 Nov; 57(6):275-82. PubMed ID: 3445769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.